1. Home
  2. ANIX vs GNT Comparison

ANIX vs GNT Comparison

Compare ANIX & GNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ANIX
  • GNT
  • Stock Information
  • Founded
  • ANIX 1982
  • GNT 2011
  • Country
  • ANIX United States
  • GNT United States
  • Employees
  • ANIX N/A
  • GNT N/A
  • Industry
  • ANIX Biotechnology: Pharmaceutical Preparations
  • GNT Finance/Investors Services
  • Sector
  • ANIX Health Care
  • GNT Finance
  • Exchange
  • ANIX Nasdaq
  • GNT Nasdaq
  • Market Cap
  • ANIX 87.1M
  • GNT 88.1M
  • IPO Year
  • ANIX 1987
  • GNT N/A
  • Fundamental
  • Price
  • ANIX $2.80
  • GNT $5.60
  • Analyst Decision
  • ANIX Strong Buy
  • GNT
  • Analyst Count
  • ANIX 1
  • GNT 0
  • Target Price
  • ANIX $7.00
  • GNT N/A
  • AVG Volume (30 Days)
  • ANIX 136.9K
  • GNT 40.9K
  • Earning Date
  • ANIX 09-04-2024
  • GNT 01-01-0001
  • Dividend Yield
  • ANIX N/A
  • GNT 6.61%
  • EPS Growth
  • ANIX N/A
  • GNT N/A
  • EPS
  • ANIX N/A
  • GNT 0.95
  • Revenue
  • ANIX N/A
  • GNT N/A
  • Revenue This Year
  • ANIX N/A
  • GNT N/A
  • Revenue Next Year
  • ANIX N/A
  • GNT N/A
  • P/E Ratio
  • ANIX N/A
  • GNT $5.36
  • Revenue Growth
  • ANIX N/A
  • GNT N/A
  • 52 Week Low
  • ANIX $2.15
  • GNT $4.59
  • 52 Week High
  • ANIX $5.13
  • GNT $5.40
  • Technical
  • Relative Strength Index (RSI)
  • ANIX 54.47
  • GNT 56.16
  • Support Level
  • ANIX $2.78
  • GNT $5.53
  • Resistance Level
  • ANIX $3.44
  • GNT $5.72
  • Average True Range (ATR)
  • ANIX 0.23
  • GNT 0.07
  • MACD
  • ANIX 0.04
  • GNT -0.01
  • Stochastic Oscillator
  • ANIX 52.03
  • GNT 50.00

About ANIX Anixa Biosciences Inc.

Anixa Biosciences Inc, a cancer-focused biotechnology company, developing vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.

About GNT GAMCO Natural Resources Gold & Income Trust

GAMCO Natural Resources, Gold & Income Trust is a non-diversified closed-end management investment company. The company's primary investment objective is to provide a high level of current income from interest, dividends, and options premiums with its secondary objective being capital appreciation. Under normal market conditions, the company invests majority of its assets in securities of companies principally engaged in the natural resources and gold industries, and also engages in writing covered call options on the underlying equity securities. Its portfolio consists of securities from different sectors such as metals and mining, energy and energy services, specialty chemicals, agriculture, healthcare, machinery, food and beverage, and others.

Share on Social Networks: